Journal of Personalized Medicine 
Journal Title
- Journal of Personalized Medicine
ISSN
- 2075-4426
Publisher
- MDPI AG
Listed on(Coverage)
| JCR | 2019 |
|---|---|
| SJR | 2013-2015;2017-2019 |
| CiteScore | 2017-2019 |
| SCIE | 2019-2021 |
| CC | 2019-2021 |
| SCOPUS | 2017-2020 |
| DOAJ | 2017-2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | individualized medicine |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY |
| Copyrights | Yes |
| DOAJ Coverage |
|
| Subject(s) | Medicine |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- SWITZERLAND
Aime & Scopes
- Aims Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis). For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities. Scope Topics of interest with a view towards personalized medicine include (but are not limited to) the following: /// Omics-based studies of disease risk, disease prognosis, and response to therapy /// Biomarker identification and application /// Drug target discovery and integration with individualized therapy /// Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism /// Prediction-based drug safety /// Novel therapeutics: genetic-based, nanotechnology, targeting strategies /// Advancements in Technologies and Resources /////// Genetic testing, sequencing technologies, and molecular diagnostics /////// Expression analysis, metabolomics, proteomics /////// Microbiomes /////// Genome-wide association studies /////// Bioinformatics and health informatics /////// Biostatistics /// Personalization of omics-based non-drug related health interventions /// Regulation and bioethics in personalized medicine